Hefei Lifeon Pharmaceutical Co., Ltd. Stock: price and insider trades · China
立方制药
Hefei Lifeon Pharmaceutical Co., Ltd.: what insiders have been doing
Hefei Lifeon Pharmaceutical Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Nothing new has been filed by managers of Hefei Lifeon Pharmaceutical Co., Ltd. in twelve months, the latest record being from 21 June 2023.
Since 2022, the database holds no purchases and 11 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,000 shares10.8% of flowA股XSHESZSE:173000006680026460
- 4,000 shares10.9% of flowA股XSHESZSE:173000006672223800
- 3,000 shares8.6% of flowA股XSHESZSE:173000006669480220
- 5,000 shares14.2% of flowA股XSHESZSE:173000006666953950
- 2,000 shares5.7% of flowA股XSHESZSE:173000006663043170
- 5,000 shares14.5% of flowA股XSHESZSE:173000006660074430
- 12,000 shares35.3% of flowA股XSHESZSE:173000006657349250
- 10,000 shares33.7% of flowA股XSHESZSE:173000006314948540
- 20,000 shares66.3% of flowA股XSHESZSE:173000006064224900
- 7,000 shares19.9% of flowA股XSHESZSE:173000005965869500
- 28,000 shares80.1% of flowA股XSHESZSE:173000005962872960
11 of 11 declarations
About Hefei Lifeon Pharmaceutical Co., Ltd.
立方制药 is a company focused on the health and pharmaceutical sector, dedicated to the development of innovative drugs. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
